亚太蛋白质组学市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按类型(仪器、试剂、服务和软件)、应用和地理划分

市场快照

CAGR
Study Period: 2018 - 2026
Base Year: 2021
CAGR: 7.6 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

由于个性化医疗需求的增加、研发支出的增加和政府对蛋白质组学的资助以及技术的进步,预计亚太地区蛋白质组学市场将出现高速增长。

这些主要驱动力将继续推动生物制药行业对重磅药物的追求以及基因和蛋白质研究的最新技术进步。联盟在这一领域变得越来越重要,因为公司很难找到所有必要的专业知识来涵盖蛋白质组学所涉及的所有活动。例如,许多公司都在使用质谱,制造商和最终用户实验室都在与蛋白质芯片相关公司合作。对个性化药物的需求增加和蛋白质组学研发的增加也是市场的驱动因素。 

Scope of the report

As per the scope of the report, proteomics is the study of protein structure and function. At the cellular level, proteomics deal with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.

Type
Instrument
Spectroscopy
Chromatography
Electrophoresis
Protein Microarrays
X-Ray Crystallography
Other Instrumentation Technologies
Reagents
Services and Software
Application
Clinical Diagnostics
Drug Discovery
Other Applications
Geography
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Report scope can be customized per your requirements. Click here.

主要市场趋势

光谱领域预计将在预测期内实现高增长

基于质谱的蛋白质组学技术的最新进展导致积累了大量的蛋白质组学信息。这些信息使科学家能够识别蛋白质特征或蛋白质生物标志物,可用于改善癌症诊断、预后和治疗。例如,基于质谱的蛋白质组学已被用于乳腺癌研究以阐明蛋白质功能。乳腺癌是一组异质性疾病,具有不同的分子特征,反映在肿瘤特征和临床结果中。与所有其他乳腺癌亚型相比,三阴性乳腺癌在性质和异质性上可能是最明显的。

多年来,亚太地区的乳腺癌患病率呈上升趋势。例如,根据《危疾杂志》2016 年发表的一份报告,新加坡的年龄标准化乳腺癌发病率已从 1968 年至 1972 年期间的每年每 10 万人中的 20.2 人增加到 2006 年至 2010 年期间的每年每 10 万人中的 60.7 人。根据该报告,在过去 10 年中,中国和印度的发病率增加了高达 30%,而在日本、韩国和新加坡,发病率在过去几十年中增加了一倍甚至三倍。

随着乳腺癌发病率的增加,对光谱蛋白质组学的需求预计也会增加。预计这将有助于亚太地区蛋白质组学市场的增长。

Graph.png

竞争格局

亚太地区大部分国家都是发展中国家。这些发展中经济体有大量无人看管的疾病。因此,这些国家的医院供应潜力很大,因此对于全球参与者进入市场来说是非常有利可图的。因此,该地区拥有蛋白质组学市场中大多数全球参与者的存在。此外,还有一些区域参与者也在该地区建立了自己的存在。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Demand for Personalized Medicine

      2. 4.2.2 Increasing R&D Expenditure and Government Funding for Proteomics

      3. 4.2.3 Technological Advancements

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Instruments

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Type

      1. 5.1.1 Instrument

        1. 5.1.1.1 Spectroscopy

        2. 5.1.1.2 Chromatography

        3. 5.1.1.3 Electrophoresis

        4. 5.1.1.4 Protein Microarrays

        5. 5.1.1.5 X-Ray Crystallography

        6. 5.1.1.6 Other Instrumentation Technologies

      2. 5.1.2 Reagents

      3. 5.1.3 Services and Software

    2. 5.2 Application

      1. 5.2.1 Clinical Diagnostics

      2. 5.2.2 Drug Discovery

      3. 5.2.3 Other Applications

    3. 5.3 Geography

      1. 5.3.1 Asia-Pacific

        1. 5.3.1.1 China

        2. 5.3.1.2 Japan

        3. 5.3.1.3 India

        4. 5.3.1.4 Australia

        5. 5.3.1.5 South Korea

        6. 5.3.1.6 Rest of Asia-Pacific

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Agilent Technologies, Inc.

      2. 6.1.2 Bio-Rad Laboratories, Inc.

      3. 6.1.3 Bruker Corporation

      4. 6.1.4 Danaher Corporation

      5. 6.1.5 GE Healthcare

      6. 6.1.6 Merck KGaA

      7. 6.1.7 Promega Corporation

      8. 6.1.8 Thermo Fisher Scientific, Inc.

      9. 6.1.9 Waters Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Proteomics Market market is studied from 2018 - 2026.

The Asia-Pacific Proteomics Market is growing at a CAGR of 7.6% over the next 5 years.

Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, GE Healthcare, Thermofischer Scientific Inc. are the major companies operating in Asia-Pacific Proteomics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!